MARKET PULSE-Sarepta, Xyratex, Family Dollar, Metro PCS, Arqule

Oct 3 (Reuters) - Some U.S. stocks on the move on Wednesday:

(For the Morning News Call newsletter click on ;

For The Day Ahead newsletter click on )

Wall St opens slightly higher after ADP

U.S. stocks rose slightly at the open on Wednesday after data showed more jobs were created in the U.S. private sector last month than analysts had expected.

The Dow Jones industrial average gained 0.11 percent. The Standard & Poor's 500 Index added 0.17 percent. The Nasdaq Composite Index rose 0.37 percent.

** SAREPTA THERAPEUTICS INC , $30.30, up 102 pct (0950 ET)

The company said its experimental drug improved walking ability in patients with a rare muscle disorder, sending its shares soaring in premarket trade.

** INTERMUNE INC , $9.74, up 10 pct (0952 ET)

The biotechnology company said Canadian health regulators approved its drug to treat idiopathic pulmonary fibrosis, a fatal lung disease.

** XYRATEX LTD , $7.54, down 13.5 pct (0953 ET)

The network and storage equipment maker's third-quarter results missed analysts estimates as demand in the enterprise sector fell. The company forecast a surprise loss for the current quarter.

Brean Murray cut its price target on the stock.

** RIGEL PHARMACEUTICALS INC , $9.44, down 8.8 pct (0956 ET)

The clinical-stage drug development company announced a public offering of 13.7 million common shares priced at $9.50 each.

** FAMILY DOLLAR STORES INC , $69.29, up 4.8 pct (0958 ET)

The discount retailer reported a higher quarterly profit that met analysts' estimates, as increased sales of food and other basic goods brought shoppers into the stores and did not pressure margins as much as expected.

** MONSANTO CO , $88.13, down 2.6 pct (1000 ET)

The global agribusiness group posted a fourth-quarter loss, as expected, amid a seasonally sluggish sales period, and offered a conservative outlook for the new year.

** BEST BUY CO INC , $17.43, up 2.7 pct (1002 ET)

The company's founder Richard Schulze and at least four private equity firms have started examining the books of the world's largest consumer electronics chain, in early steps toward what could become a potential $11 billion buyout, according to people familiar with the matter.

** METROPCS INC , $12.50, down 7.9 pct (1003 ET)

Deutsche Telekom and MetroPCS said they will merge their U.S. mobile operations to create a larger fourth-place player better able to compete with rivals.

** B&G FOODS INC , $30.40, down 2.4 pct (1006 ET)

The company, which sells Ortega Mexican food and Cream of Wheat hot cereals, said it priced its public offering of 3.6 million shares at $30.25 per share - a 3.5 percent discount. The proceeds from the offering would be used to pay down its debt and costs related to the acquisition of the New York Style and Old London brands.

** WALGREEN CO , Tuesday close $36.20, down 1.9 pct (1007 ET)

The largest U.S. drugstore chain reported a nearly 8 percent decline in September sales as calendar day shifts hurt pharmacy sales along with generic drug introductions.

** SOURCEFIRE INC , $45.69, down 4.7 pct (1009 ET)

The cyber-security software maker said on Tuesday that Chief Executive John Burris will step down, effective immediately, three months after he had taken medical leave of absence to undergo treatment for colon cancer.

** ARQULE INC , $2.29, up 5 pct (1009 ET)

The stock regained some value after plunging about 60 percent on Tuesday when the biotechnology company said it will discontinue a late-stage trial of a lung cancer drug it was co-developing with Japan's Daiichi Sankyo Co Ltd .

** ANTARES PHARMA INC , $4.05, down 7.9 pct (1018 ET)

The company said its public offering of 12.5 million shares was priced at $4 per share, resulting in net proceeds of $47 million.

** BIOLINE RX LTD , $3.01, up 15.5 pct (1020 ET)

Aegis Capital initiated coverage of the Israeli biopharmaceutical company with a "buy" rating and a price target of $11 per share, saying the company was one of the most undervalued entities in the biotechnology sector.

** BIOLASE INC , $2.11, up 27 pct (1021 ET)

The company said the health regulators in Europe and the United States granted approval to its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.

** GENETIC TECHNOLOGIES LTD , $3.72, up 4.2 pct (1022 ET)

Phenogen Sciences, the U.S. unit of the Australia-based company, launched its lead cancer test BrevaGen in 49 states in the United States. The genetic test maker said it expects to sell the product, designed to help physicians assess breast cancer risk in patients, in New York next year.

** HEARTLAND PAYMENT SYSTEMS INC , $30.13, down 8.1 pct (1020 ET)

Stifel Nicolaus cut the company's stock to 'sell' saying the company was at risk from falling prices in the small and midsized enterprises segment where start-ups like Square Inc are gaining traction.

** OCWEN FINANCIAL CORP , $34.59, up 19.4 pct (1019 ET)

The loan servicer will buy Homeward Residential Holdings Inc from private equity firm WL Ross & Co LLC for about $750 million to strengthen its hold on the residential mortgage servicing market.

** NETFLIX INC , $60.83 up 7.7 pct (1018 ET)

Citi Investment Research said Netflix's generally positive track record and reasonable valuation made the online streaming video company a "screaming" buy, despite significant risks.

(Complied by Aditi Shrivastava in Bangalore)

(, within U.S. +1 646 223 8780, outside U.S. +91 80 4135 5783, Reuters messaging: